fr

EN DE

fr

EN DE

Publications

2085 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2024

Heliyon

Lerouge L

Non-targeted effects of radiation therapy for glioblastoma.

2024

European journal of nuclear medicine and molecular imaging

Treglia G

[F]Fluorocholine PET/CT as First-Line vs. Second-Line Imaging Method to localize parathyroid adenomas in primary hyperparathyroidism: "Game, Set, and Match".

2024

Cancers

André C

HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity.

2024

Surgery

Addeo P

Minimally invasive versus open distal pancreatectomy for resectable pancreatic neuroendocrine tumors: A propensity score matched multicentric comparative French study.

2024

Cancers

Lebas A

Complications and Risk Factors in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy.

2024

Journal of experimental & clinical cancer research : CR

Durand M

A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.

2024

Cancers

Herbein G

Cellular Transformation by Human Cytomegalovirus.

2024

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Somme LB

Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic Drivers.

2024

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Borel C

Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial.

2024

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Botsen D

Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial.